Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARTA: Alpha-1 MP in Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
NCT01983241Phase 3Completed
- Sponsor
- Grifols
- Start
- Apr 2014
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of alpha1-proteinase inhibitor in pulmonary emphysema, sponsored by Grifols. Started Apr 2014; status: completed.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
pulmonary emphysema
Beyond the preview
Go deeper on NCT01983241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01983241.